Orkla India IPO Day 3 LIVE: Issue Subscribed 6.2x; GMP Indicates 9% Listing Gain — Should You Invest in MTR’s Parent Company?
Orkla India IPO, parent of MTR and Eastern, subscribed 6.2x on Day 3. GMP at ₹70 suggests 9% listing gains. Check issue details, expert views, and subscription advice.
Orkla India IPO Day 3: Issue Subscribed 6.2x, GMP Hints 9% Listing Gain — Apply or Skip?

The Orkla India IPO, the parent company behind popular Indian food brands MTR, Eastern, and Rasoi Magic, has entered its final day of subscription on Friday, October 31, 2025. Investors have their last chance today to bid for shares in the company’s ₹1,667 crore public offering.
💰 Orkla India IPO Details
The IPO is priced in the range of ₹695–₹730 per share, valuing the company at around ₹10,000 crore at the upper end. The issue is entirely an Offer for Sale (OFS) of 2.28 crore shares by existing shareholders, with no fresh equity component.
The selling shareholders include Orkla Asia Pacific Pte Ltd (promoter) and Navas Meeran and Feroz Meeran, who are partially offloading their stakes. Post-IPO, Orkla Asia Pacific and Orkla ASA will continue to hold a majority stake in the company.
Since it’s a pure OFS, the IPO proceeds will go entirely to selling shareholders, not to the company.
Formerly known as MTR Foods, Orkla India is a major player in India’s packaged food market with a portfolio that includes spices, ready-to-eat meals, instant mixes, and sweets. The company’s strong distribution network and trusted household brands have made it one of the country’s leading food companies.
📈 Orkla India IPO Subscription Status (Day 3)
As of midday on Day 3, the IPO has been subscribed 6.2 times overall, with strong participation from non-institutional and retail investors.
Here’s the latest segment-wise subscription data:
- Qualified Institutional Buyers (QIB): 0.18x
- Non-Institutional Investors (NII): 16.45x
- Retail Investors: 3.15x
- Employees: 8.37x
The IPO closes for subscription today.
🌍 Exports Driving Growth
Exports form a significant part of Orkla India’s business. For the quarter ended June 30, 2025, export revenue stood at ₹1,196.9 million (20.4% of total revenue). For the full FY25, exports contributed ₹4,861.7 million (20.6% of revenue).
The company exports to 45 countries, including major markets such as the GCC nations, the US, and Canada. According to Technopak, Eastern, one of its key brands, has been India’s largest branded spice exporter for 24 consecutive years, commanding a 22.2% market share in FY24.
💸 Orkla India IPO GMP (Grey Market Premium)
According to market observers, the Orkla India IPO GMP stands at ₹70 as of today. This implies shares are trading ₹70 above the upper price band of ₹730, indicating a potential 9–10% listing gain if the trend continues.
Shares are scheduled to list on November 6, 2025.
📊 Analyst View: “Subscribe for Long Term”
Anand Rathi has issued a “Subscribe – Long Term” rating on the IPO. The brokerage highlights Orkla India’s strong brand equity, regional understanding, and robust supply chain as key strengths.
At the upper price band, the company’s valuation stands at a P/E of 31.5x (FY26 annualized), suggesting the issue is fairly priced for a leading FMCG player.
Analysts believe Orkla India’s long-term growth will be supported by:
- Expanding domestic packaged food consumption
- Continuous product innovation and premiumisation
- Strong export market performance
🧾 Should You Apply for the Orkla India IPO?
If you’re seeking short-term listing gains, the GMP of ₹70 suggests moderate upside potential.
However, for long-term investors, Orkla India offers a stable and growing FMCG business with iconic brands and proven export leadership — making it an attractive portfolio addition for those with patience and a multi-year outlook.
Verdict:
✅ Strong brands, export presence, and consistent growth make it a solid long-term bet.
⚠️ Fully priced IPO — suitable for investors with a long-term horizon.








